Background illustration for clinical trials search

Lupus Nephritis Clinical Trials

Browse 30 lupus nephritis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Safety and Efficacy of ONT01 in Lupus

for
Lupus Nephritis (LN), Lupus Nephritis - WHO Class III,
Location: New York NY
Sponsor: Hospital for Special Surgery, New York

Sex: All

Age: 18+

Code: NCT07107659

Early_phase1, Recruiting

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

for
Lupus Nephritis
Location: New York NY, Syracuse NY, San Antonio TX
Sponsor: Autolus Limited

Sex: All

Age: 12 - 65

Code: NCT07053800

Phase2, Recruiting

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

for
Lupus Nephritis
Location: West Long Branch NJ, Willow Grove PA, Rockville MD,
Sponsor: Aurinia Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07611214

Recruiting

Dapagliflozin in Active Lupus Nephritis

for
Lupus Nephritis (LN)
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18 - 70

Code: NCT07323524

Recruiting

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

for
Lupus Nephritis (LN)
Location: Rochester MN, Houston TX, San Francisco CA
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 60

Code: NCT06975787

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

for
Systemic Lupus Erythematosus, Lupus Nephritis
Location: Boston MA, Worcester MA, Montreal, Philadelphia PA,
Sponsor: Cabaletta Bio

Sex: All

Age: 18 - 65

Code: NCT06121297

Phase1, Phase2, Recruiting

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV),
Location: New York NY, Philadelphia PA, Durham NC, Miami FL,
Sponsor: Fate Therapeutics

Sex: All

Age: 12 - 70

Code: NCT06308978

Phase1, Recruiting

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

for
Nephritis, Lupus, Lupus Erythematosus, Systemic
Location: Miami FL, Miami Lakes FL, Doral FL, Kissimmee FL,
Sponsor: Viatris Innovation GmbH

Sex: All

Age: 18 - 70+

Code: NCT07201129

Phase3, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

for
Systemic Lupus Erythematosus (With and Without Nephritis),
Location: New York NY, East Brunswick NJ, Montreal, Baltimore MD,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07085104

Phase1, Recruiting

Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor

for
SIOD, Cystinosis, FSGS, SLE Nephritis, CKD Stage 4
Location: Palo Alto CA
Sponsor: Alice Bertaina

Sex: All

Age: 1 - 30

Code: NCT05508009

Phase1, Phase2, Recruiting